The store will not work correctly when cookies are disabled.
2-Methyl-N-phenylimidazo[1,2-a]pyridine-3-carboxamide
ID: ALA3310312
Cas Number: 62772-71-8
PubChem CID: 797916
Max Phase: Preclinical
Molecular Formula: C15H13N3O
Molecular Weight: 251.29
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1nc2ccccn2c1C(=O)Nc1ccccc1
Standard InChI: InChI=1S/C15H13N3O/c1-11-14(18-10-6-5-9-13(18)16-11)15(19)17-12-7-3-2-4-8-12/h2-10H,1H3,(H,17,19)
Standard InChI Key: RZERHEVSIGJSIA-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
4.4022 -3.6456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6877 -4.0581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6877 -4.8831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4022 -5.2956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1166 -4.8831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1166 -4.0581 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5737 -2.8386 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3942 -2.7524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7297 -3.5061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5367 -3.6776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7916 -4.4622 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.1201 -3.0942 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9169 -3.3077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5003 -2.7244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2972 -2.9379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5107 -3.7348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9274 -4.3182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1305 -4.1046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8067 -2.0379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
1 6 1 0
7 8 1 0
8 9 2 0
6 9 1 0
1 7 2 0
10 11 2 0
10 12 1 0
9 10 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
13 18 2 0
12 13 1 0
8 19 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 251.29 | Molecular Weight (Monoisotopic): 251.1059 | AlogP: 2.90 | #Rotatable Bonds: 2 |
Polar Surface Area: 46.40 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.24 | CX LogP: 1.90 | CX LogD: 1.90 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.76 | Np Likeness Score: -2.33 |
References
1. Samala G, Nallangi R, Devi PB, Saxena S, Yadav R, Sridevi JP, Yogeeswari P, Sriram D.. (2014) Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors., 22 (15): [PMID:24953948] [10.1016/j.bmc.2014.05.038] |